The Profitability Pivot: How Niche Stocks Are Navigating the 2026 EconomyGlobal Report·Aug 18 at 05:12 AMGUAC+0.35%YUM+0.43%
Amphastar CFO William J. Peters melepas saham biasa senilai $183.826,4PUBT·Aug 11 at 03:57 PMAMPH-0.37%
Bank of America Securities Keeps Their Sell Rating on Amphastar Pharmaceuticals (AMPH)Tip Ranks·Aug 10 at 04:26 AMAMPH-0.37%
Amphastar Pharma | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 183.9 MEarnings Watch·Aug 6 at 05:18 PMAMPH-0.37%
Amphastar Q2 2026 Earnings: New Products Lift Revenue and Gross MarginTradingKey·Aug 6 at 03:20 PMAMPH-0.37%
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026 | AMPH Stock NewsStockTitan·Jul 28 at 09:00 PMAMPH-0.37%
Two Years to Build or Pay 200% — Which US Pharma Stocks Win?benzinga_article·Jul 24 at 05:25 AMAMPH-0.37%ANIP-2.55%
Amphastar Pharmaceuticals director Anthony T. Pierce files initial beneficial ownership statement (Form 3)PUBT·Jul 13 at 06:36 PMAMPH-0.37%
Amphastar names Anthony Pierce to board as director expands to 11 seatsPUBT·Jul 13 at 05:07 AMAMPH-0.37%
